Page results
-
The Same Day Emergency Care Unit (SDEC) is part of the Emergency Services Division at University College Hospital. It is in the same part of the hospital as the Emergency Department, on the ground floor of University College Hospital in the Elizabeth Garrett Anderson Wing.
-
The Acute Medical Unit (AMU) is a 56-bed unit located on the first floor of University College Hospital. Its primary role is to provide rapid definitive assessment, investigation and treatment for patients admitted urgently or as an emergency from the Emergency Department, and/or referred by their GP.
-
At the Cognitive Disorders Clinic, all forms of cognitive disorder are seen; however, we have particular expertise in young onset dementia, familial dementias and unusual degenerative diseases.
-
The National Hospital for Neurology and Neurosurgery (NHNN) has one of the largest, most comprehensive programmes in Europe for the evaluation and medical and surgical treatment of epilepsy.
-
The Neurogenetics Unit offers a fully integrated service encompassing clinical assessment, diagnosis, molecular genetic testing and counselling for neurogenetic conditions.
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
Typically, patient care is multidisciplinary led by consultant neuro-ophthalmologists and neurologists.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
The UCLH post-COVID service is the lead provider for North Central London (NCL) and works with borough based services to provide support and assessment for patients with ongoing symptoms (long covid) following COVID-19 infection.
File results
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment